Salubris(SZ:002294) Xin Lang Cai Jing·2025-11-26 02:32Group 1 - The core viewpoint of the news is that Shenzhen Xinlitai Pharmaceutical Co., Ltd. has seen a stock price increase of 5.38%, reaching 62.28 CNY per share, with a total market capitalization of 69.431 billion CNY as of November 26 [1] - The company was established on November 3, 1998, and went public on September 10, 2009, focusing on the research, production, and sales of pharmaceuticals and medical devices [1] - The revenue composition of the company is as follows: formulations account for 81.69%, medical devices 8.54%, raw materials 7.17%, and others 2.59% [1] Group 2 - According to data from the top ten holdings of funds, Hongtu Innovation Fund has a significant position in Xinlitai, with its healthcare stock fund reducing its holdings by 172,400 shares in the third quarter, now holding 442,900 shares, which represents 9.83% of the fund's net value [2] - The Hongtu Innovation Healthcare Stock Fund was established on October 20, 2020, with a current size of 272 million CNY and has achieved a year-to-date return of 37.27%, ranking 834 out of 4206 in its category [2] - The fund manager, Liao Xinghao, has a tenure of 4 years and 5 days, with the best fund return during this period being 48.47% and the worst being 1.77% [2]